parecoxib has been researched along with Cognitive Decline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Lu, J; Wu, C; Zhou, H; Zhou, Q; Zhu, Z | 1 |
Cai, YH; Hu, H; Hua, F; Huang, S | 1 |
Wang, LW; Xu, H; Yao, R; Zhang, Z; Zhu, YZ | 1 |
1 review(s) available for parecoxib and Cognitive Decline
Article | Year |
---|---|
Effect of parecoxib in the treatment of postoperative cognitive dysfunction: A systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Cognitive Dysfunction; Cyclooxygenase 2 Inhibitors; Female; Humans; Interleukin-6; Isoxazoles; Male; Postoperative Complications; S100 Calcium Binding Protein beta Subunit; Time Factors; Treatment Outcome | 2019 |
2 trial(s) available for parecoxib and Cognitive Decline
Article | Year |
---|---|
Effect of parecoxib sodium pretreatment combined with dexmedetomidine on early postoperative cognitive dysfunction in elderly patients after shoulder arthroscopy: A randomized double blinded controlled trial.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Arthroscopy; Bradycardia; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Cyclooxygenase 2 Inhibitors; Dexmedetomidine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Humans; Incidence; Isoxazoles; Middle Aged; Oxygen; Pain, Postoperative; Partial Pressure; Perioperative Period; Postoperative Nausea and Vomiting; Respiratory Insufficiency; Shoulder; Sufentanil; Treatment Outcome | 2017 |
Parecoxib prevents early postoperative cognitive dysfunction in elderly patients undergoing total knee arthroplasty: A double-blind, randomized clinical consort study.
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Knee; Biomarkers; Cognitive Dysfunction; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Isoxazoles; Male; Neuropsychological Tests; Pain, Postoperative | 2016 |